Stock listing

Stuttgart:41L Laboratorios Farmaceuticos Rovi, S.A. Aktie

German listing (Stuttgart) of Laboratorios Farmaceuticos Rovi, S.A. · home listing BME:ROVI

Follow Laboratorios Farmaceuticos Rovi, S.A. into a list and get an email when it puts out news.

Share price · SWB:41L

€61.90 EUR +1.85 (+3.1%)

Close on Oct 27, 2026

Day range
€61.05 – €62.10 EUROct 27, 2026
Market cap
€4.81B EURAt the close on Oct 27, 2026 · price × 77.75M shares outstanding
Laboratorios Farmaceuticos Rovi, S.A. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
BME:ROVI · Home€63.30 EUR+0.75 (+1.2%)118,719€62.15€63.55€62.05€62.55Close on Nov 2, 2026
LSE:0ILL€62.00 EUR+1.60 (+2.6%)3,001€61.10€62.15€60.00€60.40Close on Oct 27, 2026
Frankfurt:41L€61.30 EUR+0.25 (+0.4%)—€61.30€61.30€61.30€61.05Close on Oct 30, 2026
Stuttgart:41L€61.90 EUR+1.85 (+3.1%)—€61.20€62.10€61.05€60.05Close on Oct 27, 2026
Ticker
Stuttgart:41L
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Stuttgart
Currency
EUR

What changed lately

Calls

Replays

  • Laboratorios Farmaceuticos Rovi (Madrid:ROVI) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 5:00 AM ET

    Watch Transcript

Latest news

First half 2026 results press release

Jul 23, 2026

ROVI and the Regional Government of Castilla-La Mancha promote a framework of collaboration to modernise healthcare services through technological innovation

Jul 8, 2026

First three months of 2026 results press release

May 6, 2026

Laboratorios Farmaceuticos Rovi: 2025 results press release

Feb 25, 2026

Laboratorios Farmaceuticos Rovi: ROVI releases the press release in relation to the signing of the definitive collaboration agreement with Roche for the manufacture of a new medicine in development

Nov 18, 2025

First nine months of 2025 results press release

Nov 6, 2025

Laboratorios Farmaceuticos Rovi: ROVI announces a collaboration with Roche for the manufacture of a new medicine in development

Oct 21, 2025

Laboratorios Farmaceuticos Rovi: ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)

Sep 29, 2025

First half 2025 results press release

Jul 24, 2025

ROVI held its 2025 General Shareholders’ Meeting

Jun 18, 2025

All Laboratorios Farmaceuticos Rovi, S.A. news

Decks

Laboratorios Farmaceuticos Rovi, S.A. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
6 in the last 12 months · 26 in all · newest Jul 23, 2026 · oldest 2023
Calls
1 call with a replay · 1 with a transcript · latest May 6, 2026
Decks
37 decks · latest Jul 23, 2026

Where Laboratorios Farmaceuticos Rovi, S.A. is listed

ListingExchangeCountryCurrency
BME:ROVI · Home listingMadridSpainEUR
gettex:41LgettexGermanyEUR
LS Exchange:A0M0GQLS ExchangeGermanyEUR
Tradegate:41LTradegateGermanyEUR
Milan:1ROVIMilanItalyEUR
VIE:ROVIViennaAustriaEUR
Lang & Schwarz:A0M0GQLang & SchwarzGermanyEUR
LSE:0ILLLSEUnited KingdomEUR
OTC:LABFFOTCUnited StatesUSD
BMV:ROVINBMVMexicoMXN
Dusseldorf:41LDusseldorfGermanyEUR
Aquis:ROVIEAquisUnited KingdomEUR
Frankfurt:41LFrankfurtGermanyEUR
Aquis:ROVIEAquisUnited KingdomEUR
BX Swiss:41LBX SwissSwitzerlandCHF
Munich:41LMunichGermanyEUR
Stuttgart:41L · This pageStuttgartGermanyEUR
Hamburg:41LHamburgGermanyEUR
Turquoise:ROVIETurquoiseUnited KingdomEUR
BIVA:ROVINBIVAMexicoMXN

Log in to ask 6ix AI your own questions about Laboratorios Farmaceuticos Rovi, S.A.